Biennial Conference on European Pharmaceutical Law
Venue: Brussels
Event Date/Time: Apr 15, 2010 | End Date/Time: Apr 16, 2010 |
Description
(1) Pharmaceutical law and competition law:
- Pending ECJ decisions on Article 81 EC, such as GSK (C-501/06) and on Article 82 such as AstraZeneca (T-321/05) or before the European Commission such as Boehringer (COMP/B2/39246)
- Rules on merger control applicable to the pharmaceutical sector
(2) Pharmaceutical law and intellectual property law:
- Follow-up of the legislative proposal on counterfeiting of medicines (COM(2008)668) final) and involvement of the EU at the international level (WHO, IMPACT taskforce, discussions within the Council of Europe)
- Pharmaceutical patent litigation settlements, patent linkage, licensing agreements
(3) Pharmaceutical law and free movement:
- Parallel trade and free movement of goods
- Freedom of establishment of pharmacies (C-171/07)
(4) The future of pharmaceutical law in Europe:
- New projects in the pipeline: the current discussions on the clinical trial directive, follow-up of the 2008 pharmaceutical legislative package
- Emerging new technologies and legal status of borderline products